3 results
Approved WMOCompleted
Primary Objective: To determine whether topical application of Calcitriol (Silkis) 3 µg/g, Diclofenac 10% or a combination of both can lead to a 40% histological reduction (*)/increase (*) of expression of the following antibodies: Ki67 (*), BCL2…
Approved WMOCompleted
To evaluate whether dGEMRIC is suitable as outcome measure to detect changes over time, and also between intervention groups in patients with OA of the knee.
Approved WMORecruiting
The primary objective of this exploratory proof of concept clinical investigation is to confirm bulb catheter*s performance in adults already using Navina Smart.The secondary objectives and endpoints are to evaluate bowel emptying performance of…